Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2002 1
2003 1
2007 2
2009 1
2010 3
2011 9
2012 9
2013 8
2014 23
2015 29
2016 25
2017 17
2018 17
2019 9
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25035274

144 results
Results by year
Filters applied: . Clear all
Page 1
Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach.
Glassock RJ. Glassock RJ. Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1341-3. doi: 10.2215/CJN.05880614. Epub 2014 Jul 17. Clin J Am Soc Nephrol. 2014. PMID: 25035274 Free PMC article. No abstract available.
Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.
Bech AP, Hofstra JM, Brenchley PE, Wetzels JF. Bech AP, et al. Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1386-92. doi: 10.2215/CJN.10471013. Epub 2014 Jul 17. Clin J Am Soc Nephrol. 2014. PMID: 25035272 Free PMC article.
Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.
van de Logt AE, Dahan K, Rousseau A, van der Molen R, Debiec H, Ronco P, Wetzels J. van de Logt AE, et al. Kidney Int. 2018 Apr;93(4):1016-1017. doi: 10.1016/j.kint.2017.12.019. Kidney Int. 2018. PMID: 29571438 No abstract available.
Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.
Guerry MJ, Vanhille P, Ronco P, Debiec H. Guerry MJ, et al. Kidney Int. 2016 Jun;89(6):1399. doi: 10.1016/j.kint.2015.11.032. Kidney Int. 2016. PMID: 27181779 Free article. No abstract available.
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.
Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA. Hoxha E, et al. Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1883-90. doi: 10.2215/CJN.03850414. Epub 2014 Sep 29. Clin J Am Soc Nephrol. 2014. PMID: 25267554 Free PMC article.
Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy.
Li C, Li H, Wen YB, Li XM, Li XW. Li C, et al. BMC Nephrol. 2018 Dec 12;19(1):354. doi: 10.1186/s12882-018-1160-6. BMC Nephrol. 2018. PMID: 30541581 Free PMC article.
Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.
Brenchley PE. Brenchley PE. J Am Soc Nephrol. 2015 Oct;26(10):2308-11. doi: 10.1681/ASN.2015020181. Epub 2015 Mar 24. J Am Soc Nephrol. 2015. PMID: 25804283 Free PMC article. No abstract available.
Treatment of primary membranous nephropathy: where are we now?
Angioi A, Lepori N, López AC, Sethi S, Fervenza FC, Pani A. Angioi A, et al. J Nephrol. 2018 Aug;31(4):489-502. doi: 10.1007/s40620-017-0427-5. Epub 2017 Sep 5. J Nephrol. 2018. PMID: 28875476 Review.
Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V. Kumar V, et al. Nephrology (Carlton). 2015 Aug;20(8):572-5. doi: 10.1111/nep.12478. Nephrology (Carlton). 2015. PMID: 26194981
Pharmacological treatment of primary membranous nephropathy in 2016.
van de Logt AE, Hofstra JM, Wetzels JF. van de Logt AE, et al. Expert Rev Clin Pharmacol. 2016 Nov;9(11):1463-1478. doi: 10.1080/17512433.2016.1225497. Epub 2016 Sep 16. Expert Rev Clin Pharmacol. 2016. PMID: 27535699 Review.
144 results
Jump to page